Role of LPS/CD14/TLR4-mediated inflammation in necrotizing enterocolitis: pathogenesis and therapeutic implications.
about
The intestinal microbiome in early life: health and diseasePaneth-cell-disruption-induced necrotizing enterocolitis in mice requires live bacteria and occurs independently of TLR4 signalingProphylactic uses of integrin CD18-betaA peptide in a murine polymicrobial peritonitis model.Evidence-based feeding strategies before and after the development of necrotizing enterocolitis.TRIF modulates TLR5-dependent responses by inducing proteolytic degradation of TLR5Basic and translational understandings of microbial recognition by toll-like receptors in the intestine.Intestinal microbiota and blue baby syndrome: probiotic therapy for term neonates with cyanotic congenital heart diseaseNew insights into the pathogenesis and treatment of necrotizing enterocolitis: Toll-like receptors and beyondThe effect of low or high molecular weight oat beta-glucans on the inflammatory and oxidative stress status in the colon of rats with LPS-induced enteritis.Association of neonatal necrotizing enterocolitis with myeloid differentiation-2 and GM2 activator protein genetic polymorphisms.Breast milk protects against the development of necrotizing enterocolitis through inhibition of Toll-like receptor 4 in the intestinal epithelium via activation of the epidermal growth factor receptorElevated lipopolysaccharide in the colon evokes intestinal inflammation, aggravated in immune modulator-impaired mice.Cellular strain amplifies LPS-induced stress signaling in immature enterocytes: potential implications for preterm infant NCPAP.Mechanisms of gut barrier failure in the pathogenesis of necrotizing enterocolitis: Toll-like receptors throw the switch.Mapping the New World of Necrotizing Enterocolitis (NEC): Review and Opinion.Study on the inflammatory intervention of erythropoietin on NECModeling the interactions of bacteria and Toll-like receptor-mediated inflammation in necrotizing enterocolitis.Oral administration of surfactant protein-a reduces pathology in an experimental model of necrotizing enterocolitis.Tripterygium wilfordii bioactive compounds as anticancer and anti-inflammatory agents.Toll-like receptor regulation of intestinal development and inflammation in the pathogenesis of necrotizing enterocolitis.Human Milk Components Modulate Toll-Like Receptor-Mediated InflammationLPS Induces Hyper-Permeability of Intestinal Epithelial Cells.Experimental Anti-Inflammatory Drug Semapimod Inhibits TLR Signaling by Targeting the TLR Chaperone gp96.Surfactant protein-D attenuates the lipopolysaccharide-induced inflammation in human intestinal cells overexpressing toll-like receptor 4.mRNA expression of TLR4, TLR9 and NF-κB in a neonatal murine model of necrotizing enterocolitis.Stress-induced intestinal necrosis resulting from severe trauma of an earthquake.Tanshinone IIA Sodium Sulfonate Attenuates LPS-Induced Intestinal Injury in Mice.Fetal lipopolysaccharide exposure modulates diet-dependent gut maturation and sensitivity to necrotising enterocolitis in pre-term pigs.Berberine ameliorates neonatal necrotizing enterocolitis by activating the phosphoinositide 3-kinase/protein kinase B signaling pathway.
P2860
Q26996343-AFDF6E93-EDB8-4C21-A843-245C85B1994CQ33830506-78FB87A5-EDB0-4E14-A0BC-DF7E0D1DA7C2Q33894207-28349729-9E60-4A48-B459-95638651EB50Q33962474-DEAE7920-DADA-4D96-BA37-52B4685DB90EQ33967283-587A92C1-34C9-47C7-9C3C-4A86F9F4A45AQ34588751-2F8CA8B7-6924-4C02-AEB1-93D7F6615C59Q34664102-5FBE05F9-4F83-419C-A80A-F45558582528Q35073720-6F5C25AC-36AC-4D78-9F15-39BD2060B9DCQ35529030-043E313A-F3C5-46B7-ACBB-DDDD77D70DD6Q35628572-8226DBD7-E648-4D82-A67E-0074400D19DBQ35967645-560CD8A0-3D93-4529-8AE4-5AD558764BA7Q36176048-67C48F95-DE4D-45FB-8B21-15B1109E95E3Q36730747-1AD56A24-9D05-4BDD-9F1B-0EE4A9EC7AF7Q36817973-5CB67947-1A5C-47DC-AA03-99739D516FB0Q36884751-CBEC5955-836B-4455-B0B7-1E96EAB27BBDQ36953385-BADDA2D8-2228-4B00-8669-8BF2C4CA3286Q36970876-1525803D-6468-4114-8F22-F1FF606DB228Q37265312-5EB63DAE-A36B-4C4A-89C4-7328697534FBQ37915623-372AC407-166F-4122-85BE-A2D50D3A4190Q38173600-67F9C856-6BDE-45B8-9231-CF1362FDACD3Q38698319-FE0476AB-245B-453A-898A-A608EC72F632Q38735352-41D2357E-E9A8-4BD7-AAE7-6EB844BBF1F6Q38770059-332F6BFC-C64A-43DC-AF6E-5BDD6CA098A4Q38824140-12AB00BF-DD14-47C0-A7E3-C6530D650A82Q41521521-119891F2-E7E6-4DEB-9ADD-CF2C3FA7676CQ41991290-F1D9D4DF-06E4-47E5-A9A8-E3F179C416A3Q53070545-C2C519B2-BC85-46E0-8402-00C0275EC995Q54359251-7985AA62-4026-40E6-B9D1-BBFF039563B4Q54982084-8254BF3D-F559-4C97-81FB-6EF841465A67
P2860
Role of LPS/CD14/TLR4-mediated inflammation in necrotizing enterocolitis: pathogenesis and therapeutic implications.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Role of LPS/CD14/TLR4-mediated ...... and therapeutic implications.
@en
Role of LPS/CD14/TLR4-mediated ...... and therapeutic implications.
@nl
type
label
Role of LPS/CD14/TLR4-mediated ...... and therapeutic implications.
@en
Role of LPS/CD14/TLR4-mediated ...... and therapeutic implications.
@nl
prefLabel
Role of LPS/CD14/TLR4-mediated ...... and therapeutic implications.
@en
Role of LPS/CD14/TLR4-mediated ...... and therapeutic implications.
@nl
P2093
P2860
P921
P356
P1476
Role of LPS/CD14/TLR4-mediated ...... and therapeutic implications.
@en
P2093
John M Luk
Kwong F Wong
Kwong L Chan
P2860
P304
P356
10.3748/WJG.15.4745
P407
P577
2009-10-01T00:00:00Z